Cardiovascular Surgical Emergencies in France, before, during and after the First Lockdown for COVID-19 in 2020: A Comparative Nationwide Retrospective Cohort Study
- PMID: 34833121
- PMCID: PMC8620591
- DOI: 10.3390/life11111245
Cardiovascular Surgical Emergencies in France, before, during and after the First Lockdown for COVID-19 in 2020: A Comparative Nationwide Retrospective Cohort Study
Abstract
Background: There are still gaps regarding the impact of the nationwide lockdown on non-COVID-19 emergency hospitalizations. This study aims to describe the trends in hospitalizations for cardiovascular surgical emergencies in France, before, during and after the first lockdown.
Materials and methods: All adults admitted for mechanical complications of myocardial infarction (MI), aortic dissection, aortic aneurysm rupture, acute and critical limb ischemia, circulatory assistance, heart transplantation and major amputation were included. This retrospective cohort study used the French National Hospital Discharge database. The numbers of hospitalizations per month in 2020 were compared to the previous three years.
Results: From January to September 2020, 94,408 cases of the studied conditions were reported versus 103,126 in the same period in 2019 (-8.5%). There was a deep drop in most conditions during the lockdown, except for circulatory assistance, which increased. After the lockdown, mechanical complications of MI and aortic aneurysm rupture increased, and cardiac transplantations declined compared with previous years.
Conclusion: We confirmed a deep drop in most cardiovascular surgical emergencies during the lockdown. The post-lockdown period was characterized by a small over-recovery for mechanical complications of MI and aortic aneurysm rupture, suggesting that many patients were able to access surgery after the lockdown.
Keywords: aortic and arterial diseases; cardiovascular emergencies; circulatory assistance; coronavirus disease 2019; hospitalizations; lockdown.
Conflict of interest statement
Yannick Béjot received honoraria for lectures or consulting fees from BMS, Pfizer, Medtronic, Amgen, Servier and Boehringer-Ingelheim outside the submitted work. Other authors: none.
Figures



References
-
- Hartnett K.P., Kite-Powell A., DeVies J., Coletta M.A., Boehmer T.K., Adjemian J., National Syndromic Surveillance Program Community of Practice Impact of the COVID-19 Pandemic on Emergency Department Visits—United States, 1 January 2019–30 May 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:699–704. doi: 10.15585/mmwr.mm6923e1. - DOI - PMC - PubMed
-
- Banerjee A., Pasea L., Harris S., Gonzalez-Izquierdo A., Torralbo A., Shallcross L., Noursadeghi M., Pillay D., Sebire N., Holmes C., et al. Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: A population-based cohort study. Lancet. 2020;395:1715–1725. doi: 10.1016/S0140-6736(20)30854-0. - DOI - PMC - PubMed
-
- Aboyans V., Ricco J.-B., Bartelink M.-L.E.L., Björck M., Brodmann M., Cohnert T., Collet J.F., Czerny M., De Carlo M., Debus S., et al. Editor’s Choice—2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) Eur. J. Vasc. Endovasc. Surg. 2018;55:305–368. doi: 10.1016/j.ejvs.2017.07.018. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources